| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 24 |
| 1 | DEXAMETHASONE | 21 |
| 2 | DEXAMETHASONE 1.5 MG | 21 |
| 3 | ONDANSETRON | 19 |
| 4 | ONDANSETRON HYDROCHLORIDE | 19 |
| 5 | RANITIDINE | 12 |
| 6 | ADALIMUMAB | 7 |
| 7 | METHOTREXATE SODIUM | 7 |
| 8 | RANITIDINE HYDROCHLORIDE | 7 |
| 9 | ETANERCEPT | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM FLUORIDE1.1%, POTASSIUM NITRATE 5% | 1 | 0.5000 |
| 1 | MIGALASTAT HYDROCHLORIDE | 1 | 0.0018 |
| 2 | BEDAQUILINE FUMARATE | 1 | 0.0007 |
| 3 | PROPYLTHIOURACIL | 1 | 0.0005 |
| 4 | BREXUCABTAGENE AUTOLEUCEL | 1 | 0.0005 |
| 5 | ZICONOTIDE ACETATE | 1 | 0.0004 |
| 6 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0004 |
| 7 | CISPLATIN | 24 | 0.0003 |
| 8 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 9 | SCOPOLAMINE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 1 | Serotonin-3 Receptor Antagonist [EPC] | 19 | 0.0001 |
| 2 | Protease Inhibitor [EPC] | 6 | 0.0001 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 4 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 6 | 0.0001 |
| 7 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 8 | Platinum-based Drug [EPC] | 25 | 0.0001 |
| 9 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |